LINC02311

Across TCGA pan-cancer cohorts, LINC02311 RNA is linked to patient survival in 13 of 34 cancer types, making it the most broadly survival-associated LINC02311 data layer.

The strongest signal is observed in mesothelioma (MESO), where higher LINC02311 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated LINC02311 expression acts as an unfavorable survival marker, although some lineages such as ESCA show a favorable association.

MESO, KIRP, and BRCA are the cancer types where LINC02311 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
MESO	OS	Tertile	III,IV	0.069	0.580	<.001	108	view →
KIRP	OS	Tertile	All	0.650	0.936	<.001	90	view →
BRCA	DFS	Tertile	All	0.632	0.904	.001	60	view →
UCEC	DFS	Tertile	All	0.737	0.901	.004	54	view →
LUSC	OS	Tertile	III,IV	0.047	0.684	<.001	36	view →
TGCT	DFS	Tertile	All	0.206	0.686	.006	36	view →
KIRC	DFS	Tertile	All	0.249	0.636	.009	36	view →
BLCA	DFS	Tertile	All	0.169	0.627	.001	27	view →
ESCA	DFS	Tertile	III,IV	0.662	0.257	.017	24	view →
COAD	OS	Tertile	All	0.026	0.871	<.001	18	view →
SKCM	DFS	Tertile	II,III,IV	0.058	0.708	<.001	18	view →
LAML	DFS	Tertile	All	0.195	0.588	.036	18	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 13 lineages.

LINC02311–MESO (OS)

Open the MESO breakdown →